MedTrace Logo

Crave Crush Neuroimaging Study

NCT02949102 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-07-19

No results posted yet for this study

Summary

The purpose of the research is to test whether a gymnemic acids (GA) lozenge will reduce reward region response to intake of high-sugar food and ad lib candy intake and whether the GA lozenge reduced reward region response to anticipated intake of high-sugar food and high-sugar food pictures relative to a placebo lozenge.

Conditions

Interventions

DIETARY_SUPPLEMENT

Crave Crush

Crave Crush is a dietary supplement that affects sweet taste receptors on the tongue.

DIETARY_SUPPLEMENT

Placebo

The placebo tablet is comparable in taste and is comprised primarily of sorbitol.

Sponsors & Collaborators

  • Cravecrush

    collaborator UNKNOWN

  • Oregon Behavioral Intervention Strategies, Inc.

    collaborator INDUSTRY

  • Oregon Research Behavioral Intervention Strategies, Inc.

    lead INDUSTRY

Principal Investigators

  • Eric Stice, Ph.D. · Oregon Research Behavioral Intervention Strategies

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-06-30
Completion
2016-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02949102 on ClinicalTrials.gov